Should There Be a Different Cardiovascular Prevention Polypill Strategy for Women and Men?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The concept of a polypill for cardiovascular disease prevention has attracted widespread attention since Wald and Law’s seminal paper in 2003. The authors estimated > 80% reduction in coronary heart disease and stroke deaths through mass application of a polypill in people aged 55 years and older. Although their proposition has been subject to criticisms and heated debate regarding side effects, efficacy, and appropriateness of the intervention, few have discussed the differential risks and benefits of a polypill for women and men and whether sex-specific polypill strategies should be developed. In this review, we discuss the benefits and drawbacks of sex-specific polypill strategies by evaluating the published literature regarding 1) sex differences in cardiovascular risk and risk reduction, 2) risks and benefits of a polypill in women compared to men, 3) anticipated hurdles to implementing a polypill strategy, 4) special considerations related to low- and middle-income country settings, and 5) potential sex-specific polypill strategies.
- Should There Be a Different Cardiovascular Prevention Polypill Strategy for Women and Men?
Current Cardiovascular Risk Reports
Volume 5, Issue 3 , pp 280-286
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Cardiovascular disease
- Author Affiliations
- 1. Departments of Preventive Medicine and Medicine (Cardiology), Northwestern University Feinberg School of Medicine, 680 North Lake Shore Drive, Suite 1400, Chicago, IL, 60611, USA
- 2. Hubert Department of Global Health, Emory University Rollins School of Public Health, 1518 Clifton Road NE, Room 7051, Atlanta, GA, 30322, USA
- 3. Hubert Department of Global Health, Emory University Rollins School of Public Health, 1518 Clifton Road NE, Room 7030, Atlanta, GA, 30322, USA